Innovative Biologics' Seed VC Round

Innovative Biologics raised a round of funding on October 24, 2007. Investors include CIT GAP Funds.

IBI has recently demonstrated that treatment of Bacillus anthracis infected mice with a combination of the antibiotic ciprofloxacin and partially purified antibodies against anthrax protective antigen…

Articles about Innovative Biologics' Seed VC Round: